Literature DB >> 8201480

Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reaction.

P Hughes1, P LaRussa, J M Pearce, M Lepow, S Steinberg, A Gershon.   

Abstract

A 5-year-old white boy in remission from acute lymphoblastic leukemia who was receiving maintenance anticancer chemotherapy had approximately 200 vesicular skin lesions 1 month after receiving live attenuated varicella vaccine. About 2 to 3 weeks later, a mild illness resembling varicella occurred in his susceptible siblings and in three of his classmates. Vaccine-type varicella-zoster virus was demonstrated by polymerase chain reaction in swab specimens from vesicular lesions in his two siblings, in whom antibody to varicella-zoster virus also developed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8201480     DOI: 10.1016/s0022-3476(05)83185-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Varicella-zoster vaccine virus: evolution in action.

Authors:  Jeffrey I Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

Review 3.  Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review.

Authors:  Mona Marin; Jessica Leung; Anne A Gershon
Journal:  Pediatrics       Date:  2019-09       Impact factor: 7.124

Review 4.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  Varicella vaccine.

Authors:  P Duff
Journal:  Infect Dis Obstet Gynecol       Date:  1996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.